Benitec Biopharma Inc. Company Profile
NASDAQ: BNTCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 8.75 0.00%
Benitec Biopharma at a glance
Benitec Biopharma Inc. (NASDAQ: BNTC) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Hayward, CA. Benitec Biopharma is led by Dr. Jerel A. Banks M.D., Ph.D. and employs about 24 people. The company's shares have traded publicly since 2015.
At a market capitalization of $313.9 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001808898, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Benitec Biopharma do?
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines in the United States. Its Silence and Replace, a DNA-directedRNA interference platform, that combines RNA interference with gene therapy to create medicines which simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene, which is in phase 1b/2a for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.
Business description based on the company's public filings.
Company information
- Legal name
- Benitec Biopharma Inc.
- Ticker
- NASDAQ: BNTC
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Jerel A. Banks M.D., Ph.D.
- Employees
- 24
- Headquarters
- 3940 Trust Way, Hayward, CA, United States
- Phone
- 510 780 0819
- Website
- benitec.com
- IPO year
- 2015
- Market cap
- $313.94M
- SEC CIK
- 0001808898
Companies similar to Benitec Biopharma
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| INDPIndaptus Therapeutics Inc. | 2.37 | +4.87% | $315.78M | vs BNTC |
| PRLDPrelude Therapeutics Incorporated | 3.88 | +1.31% | $309.64M | vs BNTC |
| CATXPerspective Therapeutics Inc. | 2.71 | +10.16% | $309.35M | vs BNTC |
| CYPHCypherpunk Technologies Inc. | 2.81 | -7.87% | $302.82M | vs BNTC |
| RLMDRelmada Therapeutics Inc. | 3.17 | -2.46% | $338.14M | vs BNTC |
| RCKTRocket Pharmaceuticals Inc. | 2.63 | +3.75% | $288.71M | vs BNTC |
| FULCFulcrum Therapeutics Inc. | 3.75 | +2.18% | $286.11M | vs BNTC |
| BIOABioAge Labs Inc. | 6.21 | -0.80% | $285.02M | vs BNTC |